Bacterial ghosts as adjuvants: mechanisms and potential

IA Hajam, PA Dar, G Won, JH Lee - Veterinary Research, 2017 - Springer
Bacterial ghosts (BG) are empty cell envelopes derived from Gram-negative bacteria. They
contain many innate immunostimulatory agonists, and are potent activators of a broad range …

Fertility control to mitigate human–wildlife conflicts: a review

G Massei, D Cowan - Wildlife Research, 2014 - CSIRO Publishing
As human populations grow, conflicts with wildlife increase. Concurrently, concerns about
the welfare, safety and environmental impacts of conventional lethal methods of wildlife …

The development of ghost vaccines trials

AM Batah, TA Ahmad - Expert review of vaccines, 2020 - Taylor & Francis
Introduction Bacterial ghosts are intact bacterial cell envelopes that are emptied of their
content by gentle biological or chemical poring methods. Ghost techniques increase the …

Biomimetic and bioinspired strategies for oral drug delivery

X Hu, G Yang, S Chen, S Luo, J Zhang - Biomaterials science, 2020 - pubs.rsc.org
Oral drug delivery remains the most preferred approach due to its multiple advantages.
Recently there has been increasing interest in the development of advanced vehicles for …

Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications

A Muhammad, J Champeimont, UB Mayr… - Expert review of …, 2012 - Taylor & Francis
Bacterial ghosts (BGs) represent vaccine delivery systems gifted with outstanding natural
adjuvant properties. BGs are empty cell envelopes of Gram-negative bacteria lacking …

Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice

J Chen, N Li, F She - Vaccine, 2014 - Elsevier
Helicobacter pylori (H. pylori) infection is associated with incidents of gastrointestinal
diseases in half of the human population. However, management of its infection remains a …

[HTML][HTML] Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives

FI Renteria-Flores, M García-Chagollán… - Vaccines, 2024 - mdpi.com
From the first report in 1891 by Dr. Coley of the effective treatment of tumors in 1000 patients
with Streptococcus and the first successful use of bacterial vectors for transferring …

Efficient Robust Yield Method for Preparing Bacterial Ghosts by Escherichia coli Phage ID52 Lysis Protein E

Y Ma, W Zhu, G Zhu, Y Xu, S Li, R Chen, L Chen… - Bioengineering, 2022 - mdpi.com
Bacterial ghosts (BGs) are nonliving empty bacterial shells without cytoplasm retaining
original morphology and identical antigenicity of natural bacteria, making them high …

In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases

E Stein, A Inic-Kanada, S Belij… - … & visual science, 2013 - iovs.arvojournals.org
Purpose.: For the successful topical administration of drugs or vaccines to treat ocular
surface diseases, efficient and well-tolerated delivery systems/carriers for conjunctival …

Delivery of a chlamydial adhesin N-PmpC subunit vaccine to the ocular mucosa using particulate carriers

A Inic-Kanada, M Stojanovic, S Schlacher, E Stein… - PloS one, 2015 - journals.plos.org
Trachoma, caused by the intracellular bacterium Chlamydia trachomatis (Ct), remains the
world's leading preventable infectious cause of blindness. Recent attempts to develop …